NEET SS 2024 DrNB Clinical Immunology and Rheumatology Paper3 Question Paper Available - Download Here with Solution PDF

a) Describe the functional anatomy of temporomandibular (TM) joint.

b) What are the various TM joint disorders?

c) How to assess for TM joint involvement?

d) How to treat TM joint involvement in arthritis?

a) What are the characteristic histopathologic findings in juvenile dermatomyositis (JDM)?

b) Discuss the common antibodies found in JDM and their clinical associations.

c) What are the management strategies for calcinosis?

a) Describe the pathogenesis of drug-induced lupus.

b) Write clinical manifestations of drug-induced lupus.

c) Enumerate differences between drug-induced lupus and systemic lupus erythematosus.

d) Write laboratory features of drug-induced lupus.

a) Write the differences between autoimmune and autoinflammatory disorders.

b) Describe the mutations in monogenic autoinflammatory diseases with examples.

c) Describe the clinical features and treatment of syndrome with deficiency of adenosine deaminase.

a) Discuss the immunopathogenesis of sarcoidosis.

b) Describe the musculoskeletal involvement in sarcoidosis.

c) How does early-onset childhood sarcoidosis differ from adult-onset sarcoidosis?

a) What do you understand by Artificial Intelligence?

b) Discuss the potential applications of Artificial Intelligence in Rheumatology.

a) Describe the role of Tyrosine Kinase 2 (Tyk2) in cytokine signaling pathways.

b) Mention the potential uses and adverse effects of Tyk2 inhibitors.

a) What is the role of occupational therapy in the management of rheumatic diseases?

b) Discuss the role of yoga in management of rheumatic diseases.

c) Describe the goals of exercise prescription in rheumatic diseases.

d) What are the various types of exercise? Give examples of each.

a) Discuss the pathogenesis of connective tissue disease-associated interstitial lung disease (CTD-ILD).

b) Write the risk factors for scleroderma-ILD.

c) Write assessment and current evidence-based treatment modalities for scleroderma-ILD.

a) Describe IL-18 biology and its role in inflammatory diseases.

b) What are the potential roles of targeting IL-18 in Rheumatology?